1887

Abstract

In a previous study, two proteins identified as hyaluronidases were detected in spent media by MS and found to be in greater quantity in the and mutant strains when compared with the parent and mutant strains of UAMS-1. In the present study, spent media and total RNA were isolated from UAMS-1 and its regulatory mutants and analysed for hyaluronidase activity and steady-state hyaluronidase () RNA message levels. Hyaluronidase activity was observed throughout all time points examined regardless of the regulatory effects of and but activity was always substantially higher in the and mutant strains than in the UAMS-1 parent and mutant strains. Northern analysis did not detect message for either the UAMS-1 parent or the mutant strains at any time point examined, while steady-state message levels were detected throughout growth for the mutant strain, but only at exponential and early post-exponential growth for the mutant strain. An biofilm plate assay, pre-coated with human plasma as a source of hyaluronic acid, demonstrated no significant increase in biofilm for a mutant strain of UAMS-1 defective in hyaluronidase activity when compared with the mutant strain. These data indicate that, while message levels and hyaluronidase activity are elevated in the mutant strains of UAMS-1, the increase in activity did not contribute to the biofilm-negative phenotype observed in the mutant strain of UAMS-1.

Funding
This study was supported by the:
  • United States Food and Drug Administration (Award E0717501)
  • National Institute of Allergy and Infectious Disease (Award AI074087)
  • National Center for Toxicological Research
  • US Department of Energy
  • US Food and Drug Administration
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.065367-0
2013-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/micro/159/4/782.html?itemId=/content/journal/micro/10.1099/mic.0.065367-0&mimeType=html&fmt=ahah

References

  1. Bae T., Schneewind O. ( 2006). Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58–63 [View Article] [PubMed]
    [Google Scholar]
  2. Beenken K. E., Blevins J. S., Smeltzer M. S. ( 2003). Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun 71:4206–4211 [PubMed] [CrossRef]
    [Google Scholar]
  3. Beenken K. E., Dunman P. M., McAleese F., Macapagal D., Murphy E., Projan S. J., Blevins J. S., Smeltzer M. S. ( 2004). Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186:4665–4684 [View Article] [PubMed]
    [Google Scholar]
  4. Blevins J. S., Beenken K. E., Elasri M. O., Hurlburt B. K., Smeltzer M. S. ( 2002). Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus . Infect Immun 70:470–480 [PubMed] [CrossRef]
    [Google Scholar]
  5. Canard B., Garnier T., Saint-Joanis B., Cole S. T. ( 1994). Molecular genetic analysis of the nagH gene encoding a hyaluronidase of Clostridium perfringens . Mol Gen Genet 243:215–224 [PubMed]
    [Google Scholar]
  6. Cassat J. E., Dunman P. M., McAleese F., Murphy E., Projan S. J., Smeltzer M. S. ( 2005). Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J Bacteriol 187:576–592 [View Article] [PubMed]
    [Google Scholar]
  7. Cassat J., Dunman P. M., Murphy E. J., Projan S. J., Beenken K. E., Palm K. J., Yang S.-J., Rice K. C., Bayles K. W., Smeltzer M. S. ( 2006). Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 152:3075–3090 [View Article] [PubMed]
    [Google Scholar]
  8. Chang S., Sievert D. M., Hageman J. C., Boulton M. L., Tenover F. C., Downes F. P., Shah S., Rudrik J. T., Pupp G. R. & other authors ( 2003). Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348:1342–1347 [View Article] [PubMed]
    [Google Scholar]
  9. Cheng Q., Yu M. C., Reeves A. R., Salyers A. A. ( 1995). Identification and characterization of a Bacteroides gene, csuF, which encodes an outer membrane protein that is essential for growth on chondroitin sulfate. J Bacteriol 177:3721–3727 [PubMed]
    [Google Scholar]
  10. Diekema D. J., Pfaller M. A., Schmitz F. J., Smayevsky J., Bell J., Jones R. N., Beach M. SENTRY Partcipants Group ( 2001). Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32:Suppl. 2S114–S132 [View Article] [PubMed]
    [Google Scholar]
  11. Diep B. A., Gill S. R., Chang R. F., Phan T. H., Chen J. H., Davidson M. G., Lin F., Lin J., Carleton H. A. & other authors ( 2006). Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus . Lancet 367:731–739 [View Article] [PubMed]
    [Google Scholar]
  12. Duthie E. S., Lorenz L. L. ( 1952). Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6:95–107 [PubMed] [CrossRef]
    [Google Scholar]
  13. Farrell A. M., Taylor D., Holland K. T. ( 1995). Cloning, nucleotide sequence determination and expression of the Staphylococcus aureus hyaluronate lyase gene. FEMS Microbiol Lett 130:81–85 [PubMed]
    [Google Scholar]
  14. Ficko-Blean E., Boraston A. B. ( 2005). Cloning, recombinant production, crystallization and preliminary X-ray diffraction studies of a family 84 glycoside hydrolase from Clostridium perfringens . Acta Crystallogr Sect F Struct Biol Cryst Commun 61:834–836 [View Article] [PubMed]
    [Google Scholar]
  15. Gertz S., Engelmann S., Schmid R., Ziebandt A.-K., Tischer K., Scharf C., Hacker J., Hecker M. ( 2000). Characterization of the σB regulon in Staphylococcus aureus . J Bacteriol 182:6983–6991 [PubMed] [CrossRef]
    [Google Scholar]
  16. Giachino P., Engelmann S., Bischoff M. ( 2001). σ(B) activity depends on RsbU in Staphylococcus aureus . J Bacteriol 183:1843–1852 [View Article] [PubMed]
    [Google Scholar]
  17. Gillaspy A. F., Hickmon S. G., Skinner R. A., Thomas J. R., Nelson C. L., Smeltzer M. S. ( 1995). Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun 63:3373–3380 [PubMed]
    [Google Scholar]
  18. Girish K. S., Kemparaju K. ( 2007). The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci 80:1921–1943 [View Article] [PubMed]
    [Google Scholar]
  19. Götz F. ( 2002). Staphylococcus and biofilms. Mol Microbiol 43:1367–1378 [View Article] [PubMed]
    [Google Scholar]
  20. Hart M. E., Smeltzer M. S., Iandolo J. J. ( 1993). The extracellular protein regulator (xpr) affects exoprotein and agr mRNA levels in Staphylococcus aureus . J Bacteriol 175:7875–7879 [PubMed]
    [Google Scholar]
  21. Hart M. E., Hart M. J., Roop A. J. ( 2009). Genotypic and phenotypic assessment of hyaluronidase among type strains of a select group of staphylococcal species. Int J Microbiol 2009:614371 [PubMed] [CrossRef]
    [Google Scholar]
  22. Hecker M., Engelmann S., Cordwell S. J. ( 2003). Proteomics of Staphylococcus aureus–current state and future challenges. J Chromatogr B Analyt Technol Biomed Life Sci 787:179–195 [PubMed] [CrossRef]
    [Google Scholar]
  23. Highlander S. K., Hultén K. G., Qin X., Jiang H., Yerrapragada S., Mason E. O. Jr, Shang Y., Williams T. M., Fortunov R. M. & other authors ( 2007). Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus . BMC Microbiol 7:99 [View Article] [PubMed]
    [Google Scholar]
  24. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F. C. ( 1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136 [PubMed] [CrossRef]
    [Google Scholar]
  25. Holden M. T. G., Feil E. J., Lindsay J. A., Peacock S. J., Day N. P. J., Enright M. C., Foster T. J., Moore C. E., Hurst L. & other authors ( 2004). Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A 101:9786–9791 [View Article] [PubMed]
    [Google Scholar]
  26. Homer K., Shain H., Beighton D. ( 1997). The role of hyaluronidase in growth of Streptococcus intermedius on hyaluronate. Adv Exp Med Biol 418:681–683 [PubMed]
    [Google Scholar]
  27. Hynes W. L., Walton S. L. ( 2000). Hyaluronidases of Gram-positive bacteria. FEMS Microbiol Lett 183:201–207 [PubMed] [CrossRef]
    [Google Scholar]
  28. Jones R. C., Deck J., Edmondson R. D., Hart M. E. ( 2008). Relative quantitative comparisons of the extracellular protein profiles of Staphylococcus aureus UAMS-1 and its sarA, agr, and sarA agr regulatory mutants using one-dimensional polyacrylamide gel electrophoresis and nanocapillary liquid chromatography coupled with tandem mass spectrometry. J Bacteriol 190:5265–5278 [View Article] [PubMed]
    [Google Scholar]
  29. Karlsson A., Arvidson S. ( 2002). Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA . Infect Immun 70:4239–4246 [View Article] [PubMed]
    [Google Scholar]
  30. Kennedy A. D., Otto M., Braughton K. R., Whitney A. R., Chen L., Mathema B., Mediavilla J. R., Byrne K. A., Parkins L. D. & other authors ( 2008). Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A 105:1327–1332 [View Article] [PubMed]
    [Google Scholar]
  31. Kersey P., Bower L., Morris L., Horne A., Petryszak R., Kanz C., Kanapin A., Das U., Michoud K. & other authors ( 2005). Integr8 and Genome Reviews: integrated views of complete genomes and proteomes. Nucleic Acids Res 33:Database issueD297–D302 [View Article] [PubMed]
    [Google Scholar]
  32. Kullik I., Giachino P., Fuchs T. ( 1998). Deletion of the alternative sigma factor σB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J Bacteriol 180:4814–4820 [PubMed]
    [Google Scholar]
  33. Laurent T. C., Fraser J. R. E. ( 1992). Hyaluronan. FASEB J 6:2397–2404 [PubMed]
    [Google Scholar]
  34. Lindsay J. A., Holden M. T. G. ( 2004). Staphylococcus aureus: superbug, super genome?. Trends Microbiol 12:378–385 [View Article] [PubMed]
    [Google Scholar]
  35. Loffler C. A., MacDougall C. ( 2007). Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Expert Rev Anti Infect Ther 5:961–981 [View Article] [PubMed]
    [Google Scholar]
  36. Makris G., Wright J. D., Ingham E., Holland K. T. ( 2004). The hyaluronate lyase of Staphylococcus aureus – a virulence factor?. Microbiology 150:2005–2013 [View Article] [PubMed]
    [Google Scholar]
  37. Maple P. A. C., Hamilton-Miller J. M. T., Brumfitt W. ( 1989). World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus . Lancet 333:537–540 [View Article] [PubMed]
    [Google Scholar]
  38. Pané-Farré J., Jonas B., Förstner K., Engelmann S., Hecker M. ( 2006). The σB regulon in Staphylococcus aureus and its regulation. Int J Med Microbiol 296:237–258 [PubMed] [CrossRef]
    [Google Scholar]
  39. Pecharki D., Petersen F. C., Scheie A. A. ( 2008). Role of hyaluronidase in Streptococcus intermedius biofilm. Microbiology 154:932–938 [PubMed] [CrossRef]
    [Google Scholar]
  40. Rautela G. S., Abramson C. ( 1973). Crystallization and partial characterization of Staphylococcus aureus hyaluronate lyase. Arch Biochem Biophys 158:687–694 [PubMed] [CrossRef]
    [Google Scholar]
  41. Rood J. I., Cole S. T. ( 1991). Molecular genetics and pathogenesis of Clostridium perfringens . Microbiol Rev 55:621–648 [PubMed]
    [Google Scholar]
  42. Saïd-Salim B., Mathema B., Kreiswirth B. N. ( 2003). Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol 24:451–455 [PubMed] [CrossRef]
    [Google Scholar]
  43. Senn M. M., Giachino P., Homerova D., Steinhuber A., Strassner J., Kormanec J., Flückiger U., Berger-Bächi B., Bischoff M. ( 2005). Molecular analysis and organization of the σB operon in Staphylococcus aureus . J Bacteriol 187:8006–8019 [PubMed] [CrossRef]
    [Google Scholar]
  44. Shain H., Homer K. A., Beighton D. ( 1996). Degradation and utilisation of chondroitin sulphate by Streptococcus intermedius . J Med Microbiol 44:372–380 [View Article] [PubMed]
    [Google Scholar]
  45. Shaw L., Golonka E., Potempa J., Foster S. J. ( 2004). The role and regulation of the extracellular proteases of Staphylococcus aureus . Microbiology 150:217–228 [View Article] [PubMed]
    [Google Scholar]
  46. Shimizu T., Ohtani K., Hirakawa H., Ohshima K., Yamashita A., Shiba T., Ogasawara N., Hattori M., Kuhara S., Hayashi H. ( 2002). Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc Natl Acad Sci U S A 99:996–1001 [View Article] [PubMed]
    [Google Scholar]
  47. Smith L. D. ( 1979). Virulence factors of Clostridium perfringens . Rev Infect Dis 1:254–262 [View Article] [PubMed]
    [Google Scholar]
  48. Snodgrass J. L., Mohamed N., Ross J. M., Sau S., Lee C. Y., Smeltzer M. S. ( 1999). Functional analysis of the Staphylococcus aureus collagen adhesin B domain. Infect Immun 67:3952–3959 [PubMed]
    [Google Scholar]
  49. Srinivasan A., Dick J. D., Perl T. M. ( 2002). Vancomycin resistance in staphylococci. Clin Microbiol Rev 15:430–438 [View Article] [PubMed]
    [Google Scholar]
  50. Starr C. R., Engleberg N. C. ( 2006). Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus. Infect Immun 74:40–48 [PubMed] [CrossRef]
    [Google Scholar]
  51. Steiner B., Cruce D. ( 1992). A zymographic assay for detection of hyaluronidase activity on polyacrylamide gels and its application to enzymatic activity found in bacteria. Anal Biochem 200:405–410 [View Article] [PubMed]
    [Google Scholar]
  52. Stern R., Jedrzejas M. J. ( 2006). Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev 106:818–839 [PubMed] [CrossRef]
    [Google Scholar]
  53. Styers D., Sheehan D. J., Hogan P., Sahm D. F. ( 2006). Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 5:2 [View Article] [PubMed]
    [Google Scholar]
  54. Taylor D., Holland K. T. ( 1989). Amino acid requirements for the growth and production of some exocellular products of Staphylococcus aureus . J Appl Bacteriol 66:319–329 [View Article] [PubMed]
    [Google Scholar]
  55. Taylor D., Holland K. T. ( 1991). Differential regulation of toxic shock syndrome toxin-1 and hyaluronate lyase production by Staphylococcus aureus . The Staphylococci, Zbl. Bakt. Suppl. 21209–212 Jeljaszewicz J., Ciborowski P. Stuttgart: Gustav Fischer Verlag;
    [Google Scholar]
  56. Tenover F. C., Weigel L. M., Appelbaum P. C., McDougal L. K., Chaitram J., McAllister S., Clark N., Killgore G., O’Hara C. M. & other authors ( 2004). Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 48:275–280 [View Article] [PubMed]
    [Google Scholar]
  57. Tsang L. H., Cassat J. E., Shaw L. N., Beenken K. E., Smeltzer M. S. ( 2008). Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS ONE 3:e3361 [View Article] [PubMed]
    [Google Scholar]
  58. Valle J., Toledo-Arana A., Berasain C., Ghigo J.-M., Amorena B., Penadés J. R., Lasa I. ( 2003). SarA and not σB is essential for biofilm development by Staphylococcus aureus . Mol Microbiol 48:1075–1087 [PubMed] [CrossRef]
    [Google Scholar]
  59. Whitener C. J., Park S. Y., Browne F. A., Parent L. J., Julian K., Bozdogan B., Appelbaum P. C., Chaitram J., Weigel L. M. & other authors ( 2004). Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 38:1049–1055 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.065367-0
Loading
/content/journal/micro/10.1099/mic.0.065367-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error